Sandoz, through Sandoz One Source, offers a comprehensive patient support program designed to help simplify patient access to Zarxio (filgrastim-sndz), a biosimilar to Neupogen.
Sanofi-Aventis offers Sanofi Patient Connection, a comprehensive set of patient support services designed to facilitate access to Sanofi’s medications to patients who are unable to afford them.
Seattle Genetics SeaGen Secure is a comprehensive reimbursement program providing personalized services to patients and helpful assistance for practices utilizing Adcetris (brentuximab vedotin) therapy. Adcetris is a CD30-directed antibody drug conjugate that is indicated for several types of lymphoma.
The Taiho Oncology Patient Support program was established in September 2015 by Taiho Oncology and provides a range of personalized support services for patients who have been prescribed Lonsurf (trifluridine and tipiracil), as well as their caregivers and healthcare providers. The support services include access and reimbursement support, specialty pharmacy prescription coordination, and copay support, based on their financial needs and insurance coverage.
Takeda Oncology 1Point program offers comprehensive services that can assist patients with coverage support, financial assistance, and other day-to-day needs associated with Alunbrig (brigatinib), Ninlaro (ixazomib), or Iclusig (ponatinib) treatment. Takeda Oncology 1Point program may be able to provide assistance for eligible patients with all insurance types through the Co‑Pay Assistance Program, the RapidStart Program, and the Patient Assistance Program.
TerSera Therapeutics offers a range of support services, including financial assistance programs and coverage support, for patients who are prescribed Varubi (rolapitant) or Zoladex (goserelin acetate implant).
TOGETHER with TESARO is Tesaro’s patient resource program that offers a suite of patient support services focused on assisting patients with access and affordability issues related to Zejula (niraparib), a poly ADP-ribose polymerase (PARP) inhibitor.
Teva Oncology offers access to oncology medications from Teva through Teva Comprehensive Oncology Reimbursement Expertise (CORE) and the Teva Cares Foundation Patient Assistance Program.
Verastem Oncology, through its Verastem Cares, offers comprehensive reimbursement and support services for patients who are prescribed Copiktra (duvelisib) capsules and are unable to afford their medication, as well as provider support programs that help them to facilitate patient access to Copiktra and secure patient reimbursements.